Physician profile
Lawrence Schmetterer
NPI 1497848154
$1,147.92
in general payments reported to CMS, 2019-2025
12 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $578 · 2021: $165 · 2022: $101 · 2023: $59.53 · 2024: $132 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $303.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $577.90 | 2020 | |
| Boston Scientific Corporation | $151.55 | 2022-2025 | Varithena Administration Pack |
| Abbott Laboratories | $80.36 | 2021-2025 | Emboshield Nav6, Esprit |
| Bard Peripheral Vascular, INC. | $75.73 | 2022-2025 | Venclose Maven Catheter |
| Leo Pharma INC. | $68.15 | 2022-2023 | Adbry |
| Lilly USA, LLC | $53.01 | 2021 | |
| Medtronic, INC. | $43.71 | 2021-2023 | Venaseal |
| Dilon Technologies, INC. | $26.40 | 2024 | Hemoblast Bellows |
| Incyte Corporation | $21.33 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $20.86 | 2023 | Imfinzi |
| Organogenesis INC. | $15.30 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $13.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Schmetterer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.